Dosidal · Switzerland

Celluvisc, Augentropfen

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:52073 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 52073
atc: S01XA20
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1993-04-19
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: S01XA20
authorisation_number: 52073
form: AUL
holder: AbbVie AG
holder_partner_nr: 1006047
it_number: 11.08.2.
name: Celluvisc, Augentropfen
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
v3qbX1eP9vrKUxBmmr9Eimhk49izEn9yoCtjRO9zeQwS0PlQYcs--fYLjAtOJbvi8tQhbj5t2oEmdlStaBWuWA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:52073 · Related records in other markets · Dosidal